1.Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, et al. The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol. 2014 Jul;16(7):896-913. doi: 10.1093/neuonc/nou087.
2.Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, et al. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2014 Sep;15(10):1100-8. doi: 10.1016/S1470-2045(14)70379-1.
3.Zhao B, Li L, Lei Q, Guan KL. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010 May;24(9):862-74. doi: 10.1101/gad.1909210.
4.Hong W, Guan KL. The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Semin Cell Dev Biol. 2012 Sep;23(7):785-93. doi: 10.1016/j.semcdb.2012.05.004.
5.Yu FX, Zhao B, Guan KL. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell. 2015 Nov 5;163(4):811-28. doi: 10.1016/j.cell.2015.10.044.
6.Orr BA, Bai H, Odia Y, Jain D, Anders RA, Eberhart CG. Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth. J Neuropathol Exp Neurol. 2011 Jul;70(7):568-77. doi: 10.1097/NEN.0b013e31821ff8d8.
7.Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007 Nov 1;21(21):2747-61. doi: 10.1101/gad.1602907.
8.Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002 Dec 6;298(5600):1912-34. doi: 10.1126/science.1075762.
9.Hergovich A, Stegert MR, Schmitz D, Hemmings BA. NDR kinases regulate essential cell processes from yeast to humans. Nat Rev Mol Cell Biol. 2006 Apr;7(4):253-64. doi: 10.1038/nrm1891.
10.Geng,W.; He, B.;Wang, M.; Adler, P.N. The tricornered gene, which is required for the integrity of epidermal cell extensions, encodes the Drosophila nuclear DBF2-related kinase. Genetics 2000, 156, 1817–1828.
11.Zallen JA, Peckol EL, Tobin DM, Bargmann CI. Neuronal cell shape and neurite initiation are regulated by the Ndr kinase SAX-1, a member of the Orb6/COT-1/warts serine/threonine kinase family. Mol Biol Cell. 2000 Sep;11(9):3177-90. doi: 10.1091/mbc.11.9.3177.
12.Wang Y, Pan P, Wang Z, Zhang Y, Xie P, Geng D, et al. β-catenin-mediated YAP signaling promotes human glioma growth. J Exp Clin Cancer Res. 2017 Sep 29;36(1):136. doi: 10.1186/s13046-017-0606-1.
- Zhang Y, Xie P, Wang X, Pan P, Wang Y, Zhang H, et al. YAP Promotes Migration and Invasion of Human Glioma Cells. J Mol Neurosci. 2018 Feb;64(2):262-272. doi: 10.1007/s12031-017-1018-6.
14.Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell. 2005 Aug 12;122(3):421-34. doi: 10.1016/j.cell.2005.06.007.
15.Pan D . The Hippo Signaling Pathway in Development and Cancer[J]. Developmental Cell, 2010, 19(4):0-505.
16.Hergovich A. The Roles of NDR Protein Kinases in Hippo Signalling. Genes (Basel). 2016 May 18;7(5):21. doi: 10.3390/genes7050021.
17.Pearce LR, Komander D, Alessi DR. The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol. 2010 Jan;11(1):9-22. doi: 10.1038/nrm2822.
18.Millward TA, Hess D, Hemmings BA. Ndr protein kinase is regulated by phosphorylation on two conserved sequence motifs. J Biol Chem. 1999 Nov 26;274(48):33847-50. doi: 10.1074/jbc.274.48.33847.
19.Wu S, Huang J, Dong J, Pan D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell. 2003 Aug 22;114(4):445-56. doi: 10.1016/s0092-8674(03)00549-x.
20.Cui DX, Zhang L, Yan XJ, Zhang LX, Xu JR, Guo YH, et al. A microarray-based gastric carcinoma prewarning system. World J Gastroenterol. 2005 Mar 7;11(9):1273-82. doi: 10.3748/wjg.v11.i9.1273.
21.Hummerich L, Müller R, Hess J, Kokocinski F, Hahn M, Fürstenberger G, et al. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development. Oncogene. 2006 Jan 5;25(1):111-21. doi: 10.1038/sj.onc.1209016.
22.Messina M, Chiaretti S, Tavolaro S, Peragine N, Vitale A, Elia L, et al. Protein kinase gene expression profiling and in vitro functional experiments identify novel potential therapeutic targets in adult acute lymphoblastic leukemia. Cancer. 2010 Jul 15;116(14):3426-37. doi: 10.1002/cncr.25113.
23.Zhang L, Tang F, Terracciano L, Hynx D, Kohler R, Bichet S, et al. NDR functions as a physiological YAP kinase in the intestinal epithelium. Curr Biol. 2015 Feb 2;25(3):296-305. doi: 10.1016/j.cub.2014.11.054.
24.Adeyinka A, Emberley E, Niu Y, Snell L, Murphy LC, Sowter H, et al. Analysis of gene expression in ductal carcinoma in situ of the breast. Clin Cancer Res. 2002 Dec;8(12):3788-95.
25.Bisikirska BC, Adam SJ, Alvarez MJ, Rajbhandari P, Cox R, Lefebvre C, et al. STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma. Oncogene. 2013 Nov 7;32(45):5283-91. doi: 10.1038/onc.2012.543.
26.Oh H, Irvine KD. Yorkie: the final destination of Hippo signaling. Trends Cell Biol. 2010 Jul;20(7):410-7. doi: 10.1016/j.tcb.2010.04.005.
- Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016 Jan 1;30(1):1-17. doi: 10.1101/gad.274027.115.
28.Debatin K M , Krammer P H . Death receptors in chemotherapy and cancer[J]. Oncogene, 2004, 23(16):2950-2966.
29.Song MS, Song SJ, Ayad NG, Chang JS, Lee JH, Hong HK, et al. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol. 2004 Feb;6(2):129-37. doi: 10.1038/ncb1091.
30.Vichalkovski A, Gresko E, Cornils H, Hergovich A, Schmitz D, Hemmings BA. NDR kinase is activated by RASSF1A/MST1 in response to Fas receptor stimulation and promotes apoptosis. Curr Biol. 2008 Dec 9;18(23):1889-95. doi: 10.1016/j.cub.2008.10.060.